Cargando…
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062948/ https://www.ncbi.nlm.nih.gov/pubmed/24794181 http://dx.doi.org/10.1016/j.jcyt.2014.02.008 |
_version_ | 1782321717271592960 |
---|---|
author | Pievani, Alice Scagliotti, Valeria Russo, Francesca Maria Azario, Isabella Rambaldi, Benedetta Sacchetti, Benedetto Marzorati, Simona Erba, Eugenio Giudici, Giovanni Riminucci, Mara Biondi, Andrea Vergani, Patrizia Serafini, Marta |
author_facet | Pievani, Alice Scagliotti, Valeria Russo, Francesca Maria Azario, Isabella Rambaldi, Benedetta Sacchetti, Benedetto Marzorati, Simona Erba, Eugenio Giudici, Giovanni Riminucci, Mara Biondi, Andrea Vergani, Patrizia Serafini, Marta |
author_sort | Pievani, Alice |
collection | PubMed |
description | BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differentiation has never been deeply investigated. METHODS: MSCs were obtained from CB and AF samples collected during cesarean sections at term and compared for their biological and differentiation properties, with particular interest in cartilage differentiation, in which quantitative real-time polymerase chain reaction and immunohistochemical analyses were performed to evaluate the expression of type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. RESULTS: We were able to isolate MSCs from 12 of 30 (40%) and 5 of 20 (25%) CB and AF units, respectively. Fluorescence in situ hybridization analysis indicated the fetal origin of isolated MSC strains. Both populations expressed mesenchymal but not endothelial and hematopoietic markers, even though we observed a lower expression of human leukocyte antigen (HLA) I in CB-MSCs. No differences in proliferation rate and cell cycle analysis could be detected. After osteogenic induction, both populations showed matrix mineralization and typical marker expression. Under chondrogenic conditions, pellets derived from CB-MSCs, in contrast with AF-MSCs pellets, were significantly larger, showed cartilage-like morphology and resulted positive for chondrocyte-associated markers, such as type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. CONCLUSIONS: Our results show that CB-MSCs and AF-MSCs collected at term differ from each other in their biological and differentiation properties. In particular, only CB-MSCs showed a clear chondrogenic potential and thus could represent an ideal candidate for cartilage-tissue engineering. |
format | Online Article Text |
id | pubmed-4062948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-40629482014-07-01 Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential Pievani, Alice Scagliotti, Valeria Russo, Francesca Maria Azario, Isabella Rambaldi, Benedetta Sacchetti, Benedetto Marzorati, Simona Erba, Eugenio Giudici, Giovanni Riminucci, Mara Biondi, Andrea Vergani, Patrizia Serafini, Marta Cytotherapy Original Paper BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differentiation has never been deeply investigated. METHODS: MSCs were obtained from CB and AF samples collected during cesarean sections at term and compared for their biological and differentiation properties, with particular interest in cartilage differentiation, in which quantitative real-time polymerase chain reaction and immunohistochemical analyses were performed to evaluate the expression of type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. RESULTS: We were able to isolate MSCs from 12 of 30 (40%) and 5 of 20 (25%) CB and AF units, respectively. Fluorescence in situ hybridization analysis indicated the fetal origin of isolated MSC strains. Both populations expressed mesenchymal but not endothelial and hematopoietic markers, even though we observed a lower expression of human leukocyte antigen (HLA) I in CB-MSCs. No differences in proliferation rate and cell cycle analysis could be detected. After osteogenic induction, both populations showed matrix mineralization and typical marker expression. Under chondrogenic conditions, pellets derived from CB-MSCs, in contrast with AF-MSCs pellets, were significantly larger, showed cartilage-like morphology and resulted positive for chondrocyte-associated markers, such as type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. CONCLUSIONS: Our results show that CB-MSCs and AF-MSCs collected at term differ from each other in their biological and differentiation properties. In particular, only CB-MSCs showed a clear chondrogenic potential and thus could represent an ideal candidate for cartilage-tissue engineering. Elsevier 2014-07 /pmc/articles/PMC4062948/ /pubmed/24794181 http://dx.doi.org/10.1016/j.jcyt.2014.02.008 Text en © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Original Paper Pievani, Alice Scagliotti, Valeria Russo, Francesca Maria Azario, Isabella Rambaldi, Benedetta Sacchetti, Benedetto Marzorati, Simona Erba, Eugenio Giudici, Giovanni Riminucci, Mara Biondi, Andrea Vergani, Patrizia Serafini, Marta Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title | Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title_full | Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title_fullStr | Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title_full_unstemmed | Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title_short | Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
title_sort | comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062948/ https://www.ncbi.nlm.nih.gov/pubmed/24794181 http://dx.doi.org/10.1016/j.jcyt.2014.02.008 |
work_keys_str_mv | AT pievanialice comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT scagliottivaleria comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT russofrancescamaria comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT azarioisabella comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT rambaldibenedetta comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT sacchettibenedetto comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT marzoratisimona comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT erbaeugenio comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT giudicigiovanni comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT riminuccimara comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT biondiandrea comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT verganipatrizia comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential AT serafinimarta comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential |